Realizing an Optimal Business Portfolio

「The group has set its vision for 2030 as “Becoming an entity that delivers peace of mind in healthcare to everyone,” along with targets for the fiscal year ending March 2031 of consolidated revenue of ¥500 billion, operating profit of ¥35 billion, and ROE of 15%. To achieve these targets, the group has adopted “深化と進化” as its basic policy and will realize the development and growth of its pharmacy, BPO, and pharmaceutical businesses.」

「Achieve growth through the two engines of developing existing businesses and making large-scale investments」

「The group aims to remain the company closest to patients even in this rapidly changing business environment. To achieve its medium-term targets in the post-COVID era, it has adopted three key themes, the expansion of scale, profit maximization, and digitalization, and is working across all businesses as one」

「The group aims to remain the company closest to patients even in this rapidly changing business environment. To achieve its medium-term targets in the post-COVID era, it has adopted three key themes, the expansion of scale, profit maximization, and digitalization, and is working across all businesses as one」

「To achieve its medium-term targets in the era of living with COVID-19, the group is working across all businesses as one to pursue the expansion of scale, profit maximization, and digitalization.」

「To achieve its medium-term targets in the era of living with COVID-19, the group restructured its business portfolio and worked across all businesses as one to pursue the expansion of scale, profit maximization, and digitalization.」

「To remain the company closest to patients even amid such dramatic social change, the group will continue to give top priority to management focused on protecting patients and employees from COVID-19. To achieve its medium-term targets in the era of living with COVID-19, the group is restructuring its business portfolio and pursuing, as one group, the expansion of scale, profit maximization, and digitalization across all businesses.」

「Going forward, the group will enhance synergies among its 3 businesses, establish an end-to-end service spanning pharmaceutical manufacturing through delivery to patients, and pursue its goal of becoming a comprehensive healthcare company.」

「As an important business strategy for achieving its medium-term targets, the group planned the pharmaceutical manufacturing and sales business as a third business following the dispensing pharmacy and BPO businesses. As the first step toward entering and expanding this business, it acquired all shares of Fujinaga Pharmaceutical Co., Ltd. on 8 August 2019.」

「In the highly profitable BPO business, the Group’s second pillar, the company is expanding earnings and working to optimize its portfolio by strengthening sales capabilities and improving productivity.」

「Against this backdrop, the group has identified the continued provision of healthcare as a key challenge. As part of its medium- to long-term management strategy, in addition to growing the dispensing pharmacy and BPO businesses as its two core pillars, the group is advancing plans for new businesses with strong synergies with its existing operations in order to create a third pillar. As competition in the industry intensifies further, the group will generate synergies through group management and build an optimal business portfolio to secure a stable earnings base.」

「In the highly profitable BPO business, the Group’s second pillar, the company is expanding earnings and working to optimize its portfolio.」

「In the highly profitable BPO business, the Group’s second pillar, the company is expanding earnings and working to optimize its portfolio.」

「In the highly profitable BPO contract business, the Group’s second pillar, the company is expanding earnings and working to optimize its portfolio.」

「The company is expanding earnings in the highly profitable, high-growth BPO contract business, its second pillar, and working to optimize its portfolio with the health-insurance pharmacy business.」

「The company is expanding earnings in the highly profitable, high-growth BPO contract business, its second pillar, and working to optimize its portfolio with the health-insurance pharmacy business.」

「The BPO outsourcing business is a highly profitable and growth-oriented business area, and we are pursuing further earnings growth to optimize its portfolio alongside the dispensing pharmacy business.」

「To secure a stable earnings base amid increasingly challenging industry conditions, the group will share management strategies across its companies, generate synergies, and achieve an optimal business portfolio.」

「Establishing a strong position in healthcare-related businesses and achieving an optimal business portfolio」